Biovail Corporation announced that the USFDA has accepted the Company's abbreviated new drug application (ANDA) for a generic formulation of 145mg and 48mg strengths of fenofibrate tablets (sold under the brand name Tricor by Abbott Laboratories). This drug has around $1.5 billion sale in US.
Friday 5 September, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment